Dystrophin upregulation in pressure-overloaded cardiac hypertrophy in rats

Cell Motility and the Cytoskeleton

Volumn 55, Issue 1, 2003, Pages 26-35

  Maeda, Masato ^a   Biro, Sadatoshi ^a   Kamogawa, Yasuyuki ^a   Hirakawa, Tatsumi ^a   Setoguchi, Manabu ^a   Tei, Chuwa ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Genes; Hypertension; Membrane; Myocytes; Proteins

Indexed keywords

DYSTROPHIN; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; CYTOSKELETON; FIBROSIS; GENE EXPRESSION; HEART MUSCLE; HEART VENTRICLE HYPERTROPHY; HYPERTENSION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MONOCYTE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOLEMMA; SKELETAL MUSCLE; UPREGULATION; WESTERN BLOTTING;

ANIMALS; CARDIOMEGALY; CELL MEMBRANE; CELL SIZE; DISEASE MODELS, ANIMAL; DYSTROPHIN; GENE EXPRESSION REGULATION; GLYCEROL-3-PHOSPHATE DEHYDROGENASE (NAD+); GLYCEROLPHOSPHATE DEHYDROGENASE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MALE; MYOCARDIUM; MYOCYTES, CARDIAC; RATS; RATS, WISTAR; RNA, MESSENGER; SARCOLEMMA; UP-REGULATION;

EID: 0037408526     PISSN: 08861544     EISSN: None     Source Type: Journal    
DOI: 10.1002/cm.10110     Document Type: Article

References (34)

1. Arahata K, Ishiura S, Ishiguro T, Tsukahara T, Suhara Y, Eguchi C, Ishihara T, Nonaka I, Ozawa E, Sugita H. 1988. Immunostaining of skeletal and cardiac surface membrane with antibody against Duchenne muscular dystrophy peptide. Nature 333:861-863.
2. Berko BA, Swift M. 1987. X-linked dilated cardiomyopathy. N Engl J Med 316:1186-1191.
3. Bies RD, Freidman D, Roberts R, Perryman MB, Caskey CT. 1992a. Expression and localization of dystrophin in human cardiac Purkinje fibers. Circulation 86:147-153.
4. Bies RD, Phelps SF, Cortez MD, Roberts R, Caskey CT, Chamberlain JS. 1992b. Human and murine dystrophin mRNA transcripts are differentially expressed during skeletal muscle, heart, and brain development. Nucleic Acids Res 20:1725-1731.
5. Black FM, Packer SE, Parker TG, Michael LH, Roberts R, Schwartz RJ, Schneider MD. 1991. The vascular smooth muscle α-actin gene is reactivated during cardiac hypertrophy provoked by load. J Clin Invest 88:1581-1588.
6. Collins JF, Pawloski-Dahm C, Davis MG, Ball N, Dorn GW, Walsh RA. 1996. The role of the cytoskeleton in left ventricular pressure overload hypertrophy and failure. J Mol Cell Cardiol 28:1435-1443.
7. Ervasti JM, Campbell KP. 1991. Membrane organization of the dystrophin-glycoprotein complex. Cell 66:1121-1131.
8. Gorecki DC, Monaco AP, Derry JMJ, Walker AP, Barnard EA, Barnard PJ. 1992. Expression of four alternative dystrophin transcripts in brain regions regulated by different promoters. Hum Mole Genet 1:505-510.
9. Grossman W, Jones D, Mclaurin LP. 1975. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 56:56-64.
10. Hoffman EP, Kunkel LM. 1989. Dystrophin abnormalities in Duchenne/Becker muscular dystrophy. Neuron 2:1019-1029.
11. Hoffman EP, Hudecki MS, Rosenberg PA, Pollina CM, Kunkel LM. 1988. Cell and fiber-type distribution of dystrophin. Neuron 1:411-420.
12. Holder E, Maeda M, Bies RD. 1996. Expression and regulation of the dystrophin Purkinje promoter in human skeletal muscle, heart, and brain. Hum Genet 97:232-239.
13. Izumo S, Lompre AM, Matsuoka R, Koren G, Schwartz K, Nadal-Ginard B, Mahdavi V. 1987. Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy. J Clin Invest 79:970-977.
14. Izumo S, Nadal-ginard B, Mahdavi V. 1988. Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc Natl Acad Sci USA 85:339-343.
15. Kamogawa Y, Biro S, Maeda M, Setoguchi M, Hirakawa T, Yoshida H, Tei C. 2001. Dystrophin-deficient myocardium is vulnerable to pressure overload. Cardiovasc Res 50:509-515.
16. Kimura S, Abe K, Suzuki M, Ogawa M, Yoshida K, Kaname T, Miike T, Yamamura K. 1997. A 900 bp genomic region from the mouse dystrophin promoter directs lacZ reporter expression only to the right heart of transgenic mice. Dev Growth Differ 39:257-265.
17. Klamut HJ, Gangopadhyay SB, Worton RG, Ray PN. 1990. Molecular and functional analysis of the muscle-specific promoter region of the Duchenne muscular dystrophy gene. Mol Cell Biol 10:193-205.
18. Komuro I, Kuribayashi M, Takaku F, Yazaki Y. 1988. Expression of cellular oncogene in the myocardium during the developmental stage and pressure-overloaded hypertrophy of the rat heart. Circ Res 62:1075-1079.
19. Malik AB, Shapiro JM, Yanics J, Rojales A, Geha AS. 1974. A simplified method for producing rapid ventricular hypertrophy in rats. Cardiovasc Res 88:801-805.
20. Milasin J, Muntoni F, Severini GM, Bartoloni L, Vatta M, Krajinovic M, Mateddu A, Angelini C, Camerini F, Falaschi A, Mestroni L, Giacca M, the Heart Muscle Disease Study Group. 1996. A point mutation in the 5′ splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathy. Hum Mol Genet 5:73-79.
21. Muntoni F, Cau M, Ganau A, Congiu R, Arvedi G, Mateddu A, Marrosu MG, Cianchetti C, Realdi G, Cao A, Melis MA. 1993. Deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N Engl J Med 329:921-925.
22. Muntoni F, Melis MA, Ganau A, Dubowitz V. 1995. Transcription of the dystrophin gene in normal tissues and in skeletal muscle of a family with X-linked dilated cardiomyopathy. Am J Hum Genet 56:151-157.
23. Nakagawa O, Ogawa Y, Itoh H, Suga S, Komatsu Y, Kishimoto I, Nishino K, Yoshimasa T, Nakao K. 1995. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. J Clin Invest 96:1280-1287.
24. Nigro G, Comi LI, Politano L, Bain RJI. 1990. The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol 26:271-277.
25. Nudel U, Zuk D, Einat P, Zeelon E, Levy Z, Neuman S, Yaffe D. 1989. Duchenne muscular dystrophy gene product is not identical in muscle and brain. Nature 337:76-78.
26. Shyu KG, Chen JJ, Shih NL, Chang H, Wang DL, Lien WP, Liew CC. 1995. Angiotensinogen gene expression is induced by cyclical mechanical stretch in cultured rat cardiomyocytes. Biochem Biophys Res Commun 211:241-248.
27. Tagawa H, Rozich JD, Tsutsui H, Narishige T, Kuppuswamy D, Sato H, McDermott PJ, Koide M, Cooper IV G. 1996. Basis for increased microtubules in pressure-hypertrophied cardiocytes. Circulation 93:1230-1243.
28. Tanaka H, Ozawa E. 1990. Expression of dystrophin mRNA and the protein in the developing rat heart. Biochem Biophys Res Commun 172:824-829.
29. Tennyson CN, Klamut HJ, Worton RG. 1995. The human dystrophin gene requires 16 hours to be transcribed and is cotranscriptionally spliced. Nature Genet 9:184-190.
30. Tennyson CN, Shi Q, Worton RG. 1996. Stability of the human dystrophin transcript in muscle. Nucleic Acids Res 24:3059-3064.
31. Towbin JA, Hejtmancik JF, Brink P, Gelb B, Zhu XM, Chamberlain JS, McCabe ERB, Swift M. 1993. X-linked dilated cardiomyopathy: molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation 87:1854-1865.
32. Usuki F, Ishiura S, Sasagawa N, Sorimachi H, Suzuki K, Simizu T, Terao T. 1995. Up-regulation of dystrophin mRNA by exposure to dibutyryl cAMP in the C2C12 muscle cell line. Biochem Biophys Res Commun 210:654-659.
33. Wang X, Li F, Campbell SE, Gerdes AM. 1999. Chronic pressure overload cardiac hypertrophy and failure in guinea pigs: II. Cytoskeletal remodeling. J Mol Cell Cardiol 31:319-331.
34. Yoshida K, Ikeda S, Nakamura A, Kagoshima M, Takeda S, Shoji S, Yanagisawa N. 1993. Molecular analysis of the Duchenne muscular dystrophy gene in patients with Becker muscular dystrophy presenting with dilated cardiomyopathy. Muscle Nerve 16:1161-1166.